ERBB2 and neoplasm: Clinical choices for the type of systemic treatment are guided by expression of estrogen receptor (ER), progesterone receptor (PR), and Human Epidermal Growth Factor Receptor 2 (HER2) in tumor biopsies, in concurrence with TNM classification, tumor grade, and age.